Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesInitiation of epoetin-[alpha] therapy at a starting dose of 120,000 units once every 3 weeks in patients with cancer receiving chemotherapy
Cancer, 01/28/09
Glaspy JA et al. - Early and standard intervention with epoetin-alpha, administered once every 3 weeks, increased and maintained hemoglobin levels within 11.0-13.0 g/dL in patients with chemotherapy-induced anemia.
Related Articles
Effect of Epoetin Alfa on Survival and Cancer Treatment-Related Anemia and Fatigue in Patients Receiving Radical Radiotherapy With Curative Intent for Head and Neck Cancer
Journal of Clinical Oncology, 11/09/09
Relevance Score: 66%
Dose reduction of epoetin-alpha in the prevention of chemotherapy-induced anaemia
Supportive Care in Cancer, 11/24/09
Relevance Score: 64%
Issues in postmenopausal hormone therapy: A 3-part CME newsletter series Counseling patients about bioidentical hormone preparations
Sexuality, Reproduction & Menopause, 11/13/09
Relevance Score: 47%
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor [alpha] therapies: Does the risk change with the time since start of treatment?
Arthritis & Rheumatism, 11/05/09
Relevance Score: 46%
Hormone Therapy Can Help Some with Prostate Cancer
MedLinePlus, 11/04/09
Relevance Score: 46%
Today in Anemia/Polycythemia...keeping you current
Receive free subspecialty "5-minute updates" via email
Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia
European Journal of Haematology, 12/10/09
Alpha-thalassaemia masked by beta gene defects and a new polyadenylation site mutation on the alpha2-globin gene
European Journal of Haematology, 12/10/09
Arterio-Arterial Anastomoses do not Prevent the Development of Twin Anemia-Polycythemia Sequence
Placenta, 12/10/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women
Breast Cancer Research and Treatment, 12/10/09
Phase II trial of temozolomide and sorafenib in advanced melanoma patients with or without brain metastases
Clinical Cancer Research, 12/10/09
A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy
Breast Cancer Research and Treatment, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor